Patient for Life
Dr. Elizabeth Chao, Ambry Chief Medical Officer, and Kelly Hagman, Senior Director Medical Affairs explain the Patient for Life Program and how Ambry’s proactive process of reanalyzing exome data with new gene disease discoveries helps families end the diagnostic odyssey for neurological and rare conditions.